(Q53358684)

13 May 2018

title

The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma. (English)

1 reference

13 May 2018

1 reference

Jung Yeon Kim

1

1 reference

13 May 2018

Tae Joo Jeon

2

1 reference

13 May 2018

Byung-Noe Bae

3

1 reference

13 May 2018

Ji Eun Kwon

4

1 reference

13 May 2018

Hyun-Jung Kim

5

1 reference

13 May 2018

Kyeongmee Park

6

1 reference

13 May 2018

Eunah Shin

7

1 reference

13 May 2018

publication date

17 August 2012

1 reference

13 May 2018

Acta Pathologica et Microbiologica Scandinavica

published in

1 reference

13 May 2018

volume

121

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

95-104

1 reference

13 May 2018

Angiogenesis inhibitors in the treatment of colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Receptor tyrosine kinases and inhibitors in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

The epidermal growth factor receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

A novel pyrrolo[3, 2-d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet-derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Cross-talk between IGF-I and TGF-beta signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

The two faces of transforming growth factor beta in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02942.X

10.1111/J.1600-0463.2012.02942.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018